Loading...
CRESTONE - Seribantumab (anti HER3 antibody) in Patients with NRG1 Gene Fusions (All Solid Tumors)
miles away / Study type: Interventional
Number of participants: 60
Sponsored by: Hospital Santa Monica
Study ID: NCTID
Recruitment Status: Actively Recruiting

Description

Lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet

Eligibility Criteria:

Lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet

Location & Contact:

LocationFacility
LocationCity, LocationState LocationZip
CentralContactEMail
CentralContactPhone

Filter Results

- Search Radius
+ Study Type
+ Phase

SurvivorNet
Patient Guides
Stay Informed.
Stay hopeful

Get critical information from SurvivorNet’s experts and hear stories of hope from survivors who’ve gotten through it.

  • Breaking medical science
  • Survivor stories

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.